These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19814728)

  • 1. Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats.
    Russell JC; Kelly SE; Vine DF; Proctor SD
    Br J Pharmacol; 2009 Nov; 158(6):1588-96. PubMed ID: 19814728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome.
    Russell JC; Kelly SE; Diane A; Wang Y; Mangat R; Novak S; Vine DF; Proctor SD
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G507-16. PubMed ID: 20508159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine.
    Russell JC; Dolphin PJ; Graham SE; Amy RM; Brindley DN
    Diabetologia; 1998 Apr; 41(4):380-9. PubMed ID: 9562341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
    Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats.
    Janiak P; Bidouard JP; Cadrouvele C; Poirier B; Gouraud L; Grataloup Y; Pierre F; Bruneval P; O'Connor SE; Herbert JM
    Eur J Pharmacol; 2006 Mar; 534(1-3):271-9. PubMed ID: 16516882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
    Muñoz MC; Argentino DP; Dominici FP; Turyn D; Toblli JE
    J Hypertens; 2006 Aug; 24(8):1607-17. PubMed ID: 16877964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats].
    Li S; Cao B; Feng QH; Li XZ
    Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):817-21. PubMed ID: 14728886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure.
    Li P; Ma LL; Xie RJ; Xie YS; Wei RB; Yin M; Wang JZ; Chen XM
    Acta Pharmacol Sin; 2012 May; 33(5):644-51. PubMed ID: 22555371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats.
    Henriksen EJ; Jacob S; Kinnick TR; Teachey MK; Krekler M
    Hypertension; 2001 Oct; 38(4):884-90. PubMed ID: 11641303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia.
    Rong X; Li Y; Ebihara K; Zhao M; Kusakabe T; Tomita T; Murray M; Nakao K
    Br J Pharmacol; 2010 Aug; 160(7):1796-807. PubMed ID: 20649581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.
    de las Heras N; Martín-Fernández B; Miana M; Ballesteros S; Oubiña MP; López-Farré AJ; Cachofeiro V; Lahera V
    J Hypertens Suppl; 2009 Aug; 27(6):S37-41. PubMed ID: 19633450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat.
    Proctor SD; Kelly SE; Stanhope KL; Havel PJ; Russell JC
    Diabetes Obes Metab; 2007 Jan; 9(1):87-95. PubMed ID: 17199723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats.
    Russell JC; Proctor SD; Kelly SE; Brindley DN
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1078-87. PubMed ID: 18413677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice].
    Ye XL; Huang WC; Zheng YT; Liang Y; Gong WQ; Yang CM; Liu B
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):505-511. PubMed ID: 28446404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.
    Hayashi M; Takeshita K; Uchida Y; Yamamoto K; Kikuchi R; Nakayama T; Nomura E; Cheng XW; Matsushita T; Nakamura S; Murohara T
    PLoS One; 2014; 9(12):e116163. PubMed ID: 25551221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis.
    Wolf G; Schneider A; Helmchen U; Stahl RA
    Exp Nephrol; 1998; 6(2):112-20. PubMed ID: 9567217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.
    Ibrahim MA; Amin EF; Ibrahim SA; Abdelzaher WY; Abdelrahman AM
    Eur J Pharmacol; 2014 Feb; 724():204-10. PubMed ID: 24370493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells.
    Kobayashi T; Akiyama Y; Akiyama N; Katoh H; Yamamoto S; Funatsuki K; Yanagimoto T; Notoya M; Asakura K; Shinosaki T; Hanasaki K
    Eur J Pharmacol; 2010 Dec; 649(1-3):23-8. PubMed ID: 20826135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial effects of antihypertensive treatment: focus on irbesartan.
    Negro R
    Vasc Health Risk Manag; 2008; 4(1):89-101. PubMed ID: 18629353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.